Jablecka A - Search Results

1

Neopterin as a prognostic marker in patients with chronic heart failure.

Wietlicka-Kokoszanek I, Jablecka A, Smolarek I, Bogdanski P, Chmara E, Korzeniowska K, Kazmierczak M, Kazmierczak E, Musialik K. Wietlicka-Kokoszanek I, et al. Among authors: jablecka a. Med Sci Monit. 2010 May;16(5):CR232-7. Med Sci Monit. 2010. PMID: 20424550

2

The acetylation and oxidation phenotypes in insulin-dependent diabetes mellitus.

Mrozikiewicz A, Kiełczewska-Mrozikiewicz D, Lowicki Z, Chmara E, Mrozikiewicz PM, Jabłecka A, Kaźmierczak E, Andrys I. Mrozikiewicz A, et al. Among authors: jablecka a. Mater Med Pol. 1995 Oct-Dec;27(4):147-9. Mater Med Pol. 1995. PMID: 9000838 Clinical Trial.

3

The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.

Jablecka A, Chmara E, Korzeniowska K. Jablecka A, et al. Int J Clin Pharmacol Res. 1998;18(4):171-8. Int J Clin Pharmacol Res. 1998. PMID: 10052027

4

The influence of two different doses of L-arginine oral supplementation on nitric oxide (NO) concentration and total antioxidant status (TAS) in atherosclerotic patients.

Jabłecka A, Checiński P, Krauss H, Micker M, Ast J. Jabłecka A, et al. Med Sci Monit. 2004 Jan;10(1):CR29-32. Med Sci Monit. 2004. PMID: 14704633 Clinical Trial.

5

[Evaluation of selected acute phase proteins in patients with metabolic syndrome].

Bogdański P, Chyrek R, Pupek-Musialik D, Jabłecka A. Bogdański P, et al. Among authors: jablecka a. Pol Merkur Lekarski. 2006 Jul;21(121):12-4. Pol Merkur Lekarski. 2006. PMID: 17007284 Polish.

6

Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus.

Bogdanski P, Pupek-Musialik D, Dytfeld J, Jagodzinski PP, Jablecka A, Kujawa A, Musialik K. Bogdanski P, et al. Among authors: jablecka a. Int J Clin Pharmacol Ther. 2007 Oct;45(10):563-7. doi: 10.5414/cpp45563. Int J Clin Pharmacol Ther. 2007. PMID: 17966842 Clinical Trial.

7

Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients.

Bogdanski P, Pupek-Musialik D, Dytfeld J, Lacinski M, Jablecka A, Jakubowski H. Bogdanski P, et al. Among authors: jablecka a. Biomed Pharmacother. 2008 Jul-Aug;62(6):360-5. doi: 10.1016/j.biopha.2007.10.019. Epub 2007 Dec 3. Biomed Pharmacother. 2008. PMID: 18093792 Clinical Trial.

8

[The evaluation of level of epigenetic indicator--5-methylcytosine in smoking and non-smoking patients with mild essential hypertension].

Smolarek I, Olszewski J, Naskret-Barciszewska M, Wyszko E, Jabłecka A. Smolarek I, et al. Among authors: jablecka a. Przegl Lek. 2007;64(10):695-7. Przegl Lek. 2007. PMID: 18409288 Polish.

9

[The pharmacokinetic of drugs in elderly patients].

Jabłecka A, Korzeniowska K, Smolarek I. Jabłecka A, et al. Pol Arch Med Wewn. 2008;118 Suppl:43-6. Pol Arch Med Wewn. 2008. PMID: 19562969 Free article. Review. Polish.

10

Influence of L-arginine on the nitric oxide concentration and level of oxidative stress during ischemia-reperfusion injury in a rat model.

Krauss H, Jablecka A, Sosnowski P, Bogdanski P. Krauss H, et al. Among authors: jablecka a. Int J Clin Pharmacol Ther. 2009 Aug;47(8):533-8. doi: 10.5414/cpp47533. Int J Clin Pharmacol Ther. 2009. PMID: 19640362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters